ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,349.45
-0.07%
Dow Jones
38,827.81
-0.15%
US Dollar vs MXN
18.4179
2.97%
Brent Oil
79.325
-0.69%
Bitcoin
69,345.84
-2.00%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Enliven Therapeutics Inc (ELVN)

  7. Enliven Therapeutics Inc (ELVN) Noticias

ELVN Enliven Therapeutics Inc

21.245
1.05 (5.17%)
Última actualización: 14:32:15
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Enliven Therapeutics Inc ELVN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
1.05 5.17% 21.245 14:32:15
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
19.95 19.55 21.95 20.20
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
31/5/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202415:08EDGAR2Form 144 - Report of proposed sale of securities
29/5/202415:06EDGAR2Form 8-K/A - Current report: [Amend]
29/5/202415:05GLOBEEnliven Therapeutics to Present at Two Upcoming Investor..
28/5/202416:45EDGAR2Form 144 - Report of proposed sale of securities
28/5/202416:29EDGAR2Form 144 - Report of proposed sale of securities
16/5/202418:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202415:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202415:10EDGAR2Form 8-K - Current report
14/5/202415:05GLOBEEnliven Therapeutics Reports First Quarter Financial Results..
13/5/202418:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202419:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202417:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202406:55GLOBEEnliven Therapeutics Announces Positive Proof of Concept..
09/4/202415:05GLOBEEnliven Therapeutics Appoints Dr. Lori Kunkel to Board of..
28/3/202415:05GLOBEEnliven Therapeutics to Share Initial Proof of Concept Data..
19/3/202407:30GLOBEEnliven Therapeutics Announces $90 Million Private Placement..
14/3/202415:05GLOBEEnliven Therapeutics Reports Fourth Quarter and Full Year..
08/3/202418:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:43EDGAR2Form 144 - Report of proposed sale of securities
04/3/202416:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:05GLOBEEnliven Therapeutics to Present at TD Cowen’s 44th Annual..
27/2/202415:02EDGAR2Form 144 - Report of proposed sale of securities
20/2/202418:35EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
16/2/202415:15EDGAR2Form SC 13D/A - General statement of acquisition of..
15/2/202420:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202420:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202415:15EDGAR2Form SC 13D/A - General statement of acquisition of..
31/1/202420:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202420:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202418:58EDGAR2Form 144 - Report of proposed sale of securities
24/1/202417:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
ELVN
Enliven Therapeutics
LSE
64YC
Cronos Rmbs B2
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados